GB9913327D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9913327D0
GB9913327D0 GBGB9913327.4A GB9913327A GB9913327D0 GB 9913327 D0 GB9913327 D0 GB 9913327D0 GB 9913327 A GB9913327 A GB 9913327A GB 9913327 D0 GB9913327 D0 GB 9913327D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9913327.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9913327.4A priority Critical patent/GB9913327D0/en
Publication of GB9913327D0 publication Critical patent/GB9913327D0/en
Priority to PCT/EP2000/005164 priority patent/WO2000074716A2/en
Priority to AU58116/00A priority patent/AU5811600A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
GBGB9913327.4A 1999-06-08 1999-06-08 Vaccine Ceased GB9913327D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9913327.4A GB9913327D0 (en) 1999-06-08 1999-06-08 Vaccine
PCT/EP2000/005164 WO2000074716A2 (en) 1999-06-08 2000-06-06 Ige peptides for allergy immunotherapy
AU58116/00A AU5811600A (en) 1999-06-08 2000-06-06 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9913327.4A GB9913327D0 (en) 1999-06-08 1999-06-08 Vaccine

Publications (1)

Publication Number Publication Date
GB9913327D0 true GB9913327D0 (en) 1999-08-11

Family

ID=10854961

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9913327.4A Ceased GB9913327D0 (en) 1999-06-08 1999-06-08 Vaccine

Country Status (3)

Country Link
AU (1) AU5811600A (en)
GB (1) GB9913327D0 (en)
WO (1) WO2000074716A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
WO2005075504A1 (en) * 2004-02-02 2005-08-18 Tanox, Inc. IDENTIFICATION OF NOVEL IgE EPITOPES
EP1930729A1 (en) * 2006-12-04 2008-06-11 Medizinische Universität Wien Method for in vivo and in vitro testing for a pharmaceutical drug induced immediate type hypersensitivity reactions
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1578348A (en) * 1976-08-17 1980-11-05 Pharmacia Ab Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic
AU2195395A (en) * 1994-03-28 1995-10-17 United Biomedical Inc. Synthetic peptide based immunogens for the treatment of allergy
CA2363637A1 (en) * 1999-02-25 2000-08-31 Smithkline Beecham Biologicals S.A. Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses

Also Published As

Publication number Publication date
WO2000074716A2 (en) 2000-12-14
WO2000074716A3 (en) 2001-07-19
AU5811600A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
IL145044A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
HUP0202885A3 (en) Vaccines
HK1105581A1 (en) Vaccine composition
EP1083926A4 (en) Vaccine
GB9910812D0 (en) Vaccine composition
GB9915204D0 (en) Vaccine
GB9901254D0 (en) Vaccines
GB0027072D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
MXPA01010701A (en) Vaccine.
GB9930591D0 (en) Component for vaccine
GB9909072D0 (en) Vaccine
GB9930585D0 (en) Component for vaccine
GB9916677D0 (en) Vaccine
GB9927336D0 (en) Vaccine
GB9904405D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9925619D0 (en) Vaccine
GB9904412D0 (en) Vaccine
GB9904408D0 (en) Vaccine
GB9905511D0 (en) Vaccine
GB9925618D0 (en) Vaccine
GB9915106D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)